Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes-Reference-Cited by-同舟云学术

Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes

Published:2024-03-07 Issue: Volume: Page:1-11
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Kobayashi Kazuhiro¹²³^ORCID,Hata Atsuko³^ORCID,Imoto Waki²^ORCID,Kakuno Shigeki²^ORCID,Shibata Wataru²^ORCID,Yamada Koichi²^ORCID,Kawaguchi Hiroshi²^ORCID,Sakurai Norihiro²^ORCID,Ito Toshikazu¹^ORCID,Uenoyama Kazuya¹,Takahashi Tamotsu¹³,Ueda Satoru¹³,Katayama Toshiro⁴^ORCID,Onoue Masahide¹,Kakeya Hiroshi²⁵⁶^ORCID

Affiliation:

1. Department of Pharmacy, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan

2. Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

3. Department of Infection Diseases, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan

4. Department of Medical Engineering, Faculty of Health Sciences, Morinomiya University of Medical Sciences, Osaka, Japan

5. Research Centre for Infectious Disease Sciences, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

6. Osaka International Research Centre for Infectious Disease, Osaka Metropolitan University, Osaka, Japan

Funder

the Japan Agency for Medical Research and Development

the Japan Society for the Promotion of Science KAKENHI

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2323326

Reference26 articles.

1. AmpC β-Lactamases

2. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?

3. The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae

4. Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused byEnterobacter,CitrobacterorSerratiaspecies: a systematic review with meta-analysis

5. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.